Investor Huang James
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Huang James . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-07-23 13G/A CASI / CASI Pharmaceuticals, Inc. 1,435,000 2,161,571
2024-11-07 13G/A ADAG / Adagene Inc. - Depositary Receipt (Common Stock) 2,750,000 4,015,000
2024-10-29 13G/A CASI / CASI Pharmaceuticals, Inc. 1,130,000 1,435,000
2024-06-11 13G/A CASI / CASI Pharmaceuticals, Inc. 2,695,000 1,130,000
2024-02-13 13G/A PRAX / Praxis Precision Medicines, Inc. 2,650,000 0
2024-01-26 13G/A CASI / CASI Pharmaceuticals, Inc. 2,695,000
2024-01-19 13G ADAG / Adagene Inc. - Depositary Receipt (Common Stock) 2,750,000
2023-11-09 13G/A CASI / CASI Pharmaceuticals, Inc. 2,427,000
2023-10-04 13G/A CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock) 2,820,000 5,995,000
2023-06-23 13G/A CASI / CASI Pharmaceuticals, Inc. 1,230,000 1,750,000
2023-05-17 13D/A WINT / Windtree Therapeutics, Inc. 75,609
2023-04-19 13D/A WINT / Windtree Therapeutics, Inc. 3,780,442
2023-04-10 13G CASI / CASI Pharmaceuticals, Inc. 1,230,000
2023-03-10 13G PRAX / Praxis Precision Medicines, Inc. 2,650,000
2023-02-23 13D/A WINT / Windtree Therapeutics, Inc. 3,780,442 3,780,442
2023-02-09 13D/A WINT / Windtree Therapeutics, Inc. 3,780,442
2023-01-03 13G CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock) 2,820,000